damianrasch.com

Myocardial Bridging: When a Heart Artery Dives Into the Muscle

Medically Reviewed & Edited

Board-Certified Invasive Cardiologist
Encinitas and La Jolla, CA

Developed with digital research and writing assistance, then medically reviewed and edited by Dr. Rasch to ensure clinical accuracy and adherence to current evidence-based guidelines.

Last reviewed and updated on June 27, 2026

A patient in his forties comes to see me with a worry he’s been carrying for weeks. He went in for a CT scan of his heart after some chest tightness during his cycling rides, and the report came back with a phrase he’d never heard: “myocardial bridging of the mid LAD.” He read about it online that night and arrived at my office braced for the worst, half expecting to hear he needed surgery on his heart. By the end of our visit he was relieved, and a little annoyed at the internet. His bridge was the kind that causes no harm at all. His chest tightness turned out to be from something else entirely, and we sorted that out.

Myocardial bridging is one of those diagnoses that sounds alarming on a report and is, for most people, completely benign. It’s also one that gets handled inconsistently, because a small but real subset of people with a bridge genuinely do have symptoms from it, and telling those two groups apart takes some care. This article walks through what a bridge actually is, why it usually doesn’t matter, why it sometimes does, how we figure out which situation you’re in, and what the treatment options look like. My goal is the same one I have in clinic: take the fear out of the word and replace it with a clear understanding of where you stand.

What a Myocardial Bridge Actually Is

To picture this, it helps to know how coronary arteries normally sit. The coronary arteries are the vessels that feed the heart muscle itself. In the usual arrangement, they run along the outer surface of the heart, resting in a thin layer of fat on top of the muscle. They sit on the roof, so to speak, and send small branches down into the muscle below.

A myocardial bridge is a spot where that pattern changes. Instead of staying on the surface, a short segment of the artery dives down into the heart muscle and runs through it for a stretch before surfacing again. The band of muscle that arches over the buried segment is called the bridge. The piece of artery running underneath it is called the tunneled segment. So the names are descriptive once you see the picture: a bridge of muscle, and a tunnel for the artery beneath it.

This is something you’re born with. It forms while the heart is developing, and it isn’t caused by anything you did or didn’t do. It’s the most common congenital coronary variation we know of, which is to say the most common way for a coronary artery to be laid out a little differently from the textbook. The artery involved is almost always the left anterior descending artery, the LAD, which is the major vessel running down the front of the heart. Studies put LAD involvement somewhere between 70 and 98 percent of bridges. Other arteries can have bridges too, but the front-of-the-heart location is far and away the most common.

One detail surprises people: a bridge is not a blockage. Atherosclerotic heart disease, the common kind, is a fixed narrowing built up from cholesterol plaque inside the artery wall. A bridge is structurally different. The artery itself is wide open and healthy. What changes is that the muscle around it squeezes it during part of each heartbeat. That distinction shapes everything about how we think about it and how we treat it.

Why It’s Usually Harmless

Here’s the part that should lower your shoulders a bit. The numbers on how often bridges turn up depend heavily on how hard you look for them, and the spread tells a story. When pathologists examine hearts carefully after death and dissect along the arteries, they find bridges in roughly 40 to 80 percent of hearts. On a detailed cardiac CT scan, bridges show up in around 58 percent of people, more than half. On a standard cardiac catheterization, where we inject dye and watch the arteries on X-ray, bridges are reported in anywhere from less than 1 percent up to 25 percent of cases.

Sit with those numbers for a second. If close to half of all human hearts have a bridge, and the rate of people walking around with symptoms from a bridge is nowhere near half, then the obvious conclusion is the right one: most bridges cause nothing at all. They are a normal anatomical variant in a huge fraction of the population. Plenty of people have one and live a full, active, symptom-free life and never know it. The reason bridges get noticed more now than they used to is simply that we image hearts in far greater detail than we once did. A finding that used to stay hidden now lands on a report.

So when a scan turns up a bridge and you feel fine, the default interpretation is reassurance. The finding by itself does not mean you have a heart problem. It means your anatomy has a common feature that, in your case, is most likely just along for the ride.

There’s even a small silver lining built into the anatomy. The tunneled segment, the buried part of the artery, tends to be protected from developing cholesterol plaque. The constant motion and the muscle wrapped around it seem to shield that stretch from the kind of buildup that causes typical heart disease. The flip side is that the segment of artery just upstream of the bridge can be more prone to plaque, because the bridge changes how blood flows and stresses the vessel wall above it. That’s a reason we still pay attention to your overall heart-disease risk factors. The bridge segment itself, though, is usually the cleanest part of the vessel.

Why It Sometimes Does Cause Symptoms

If most bridges are silent, why do some people genuinely suffer from them? The answer comes down to timing, depth, and length.

Start with timing. The heart fills its own arteries in an unusual rhythm. Most organs get their blood supply while the heart is squeezing, but the heart muscle is the exception. When the heart contracts, it clamps down on the vessels running through it, so the heart actually receives most of its own blood supply between beats, while it’s relaxed. Roughly 85 percent of coronary blood flow happens during this relaxation phase, called diastole.

Now add the bridge. Each time the heart beats and the muscle contracts, the bridge squeezes the tunneled artery and pinches it narrower. On a catheterization this looks like the artery being “milked” thinner with every beat. In a person with a shallow, short bridge, that squeeze happens during the contraction phase, when the artery isn’t doing much delivering anyway, and the vessel springs back open in time for the relaxation phase. No harm done.

The trouble starts when the squeeze lingers. Detailed ultrasound studies done inside these arteries have shown that with deeper bridges, the artery doesn’t bounce back open right away when the heart relaxes. The pinch carries over into the early part of diastole, the exact window when the heart muscle is trying to drink in its blood supply. The delivery gets shorted at the worst possible moment, and the inner layer of the heart muscle, which is the hardest to supply in the first place, feels it most. That’s the mechanism behind bridge-related symptoms.

A few features make this more likely:

Anything that makes the heart beat faster and harder will worsen all of this. When your heart rate climbs, the relaxation phase between beats shrinks, and that’s the very window a bridge is stealing from. So exercise, emotional stress, caffeine, and a racing pulse all tend to bring out symptoms in someone whose bridge is borderline. This is why a person with a symptomatic bridge often feels fine at rest and only notices chest pressure or breathlessness when they push themselves, which is exactly what my cyclist patient was worried about.

The symptoms themselves are not unique to bridging. People describe chest pressure or tightness, shortness of breath, reduced exercise tolerance, and sometimes palpitations. Because those overlap with ordinary cardiac chest pain and with plain old coronary artery disease, the symptoms alone can’t tell us the bridge is the culprit. That takes testing.

How We Diagnose a Bridge and Decide If It Matters

There are two separate questions here, and keeping them apart is the whole game. The first question is anatomical: is there a bridge, and how deep and long is it? The second question is functional: is that bridge actually choking the blood supply enough to cause harm? A scan can answer the first. It takes more to answer the second.

Coronary CT angiography, a detailed CT scan of the heart arteries, has become the best tool for the anatomical question. It shows the bridge in three dimensions, including how deep the artery dives and how long the tunneled segment runs, and how it relates to the branches. This is increasingly the test that finds bridges in the first place, and it’s very good at describing them.

Invasive coronary angiography, the dye-and-X-ray catheterization, shows the classic sign of a bridge in motion: the “milking effect,” where the tunneled segment visibly narrows with each squeeze of the heart and opens back up between beats. Watching that on the screen is the traditional way bridges were diagnosed.

Intravascular ultrasound, or IVUS, is a tiny ultrasound probe threaded inside the artery. It produces a finding specific to bridging called the half-moon sign, a crescent-shaped dark area sitting over the artery that represents the muscle of the bridge itself. Seeing it confirms the diagnosis from the inside.

The functional question, whether the bridge is causing real harm, is where things get nuanced, and it’s worth understanding because it changes decisions. The standard pressure-wire test we use for ordinary blockages, called FFR, doesn’t work reliably for bridges. The reason is mechanical. A blockage causes a fixed pressure drop, but a bridge squeezes only during contraction, and that squeeze can briefly overshoot the pressure reading and fool the standard test into looking falsely reassuring. To get around this, cardiologists who study bridges use a modified version that focuses on the relaxation phase, called diastolic FFR, often combined with a dobutamine challenge, which is a medication that safely speeds and strengthens the heart to mimic the stress of exercise. A diastolic FFR value at or below 0.76 points to a bridge that’s genuinely limiting blood flow. This kind of testing is done at centers with specific expertise, and it’s reserved for cases where the answer would actually change the plan.

There’s a useful way cardiologists sort bridge patients, sometimes called the Schwarz classification, and it maps neatly onto how worried to be:

Types B and C are the people who benefit from active treatment. Type A, the most common, mostly needs explanation and follow-up, not intervention.

How We Treat a Symptomatic Bridge

When a bridge is genuinely causing symptoms, we have a clear, stepwise approach, and we almost always start with medicine.

Beta-blockers are the first-line treatment. They work on a bridge through several mechanisms that all line up with the problem. They slow the heart rate, which lengthens the relaxation phase between beats, giving the heart more time to fill its arteries during the window the bridge is squeezing. They also reduce how forcefully the heart contracts, which softens the squeeze itself, and they calm the adrenaline drive that worsens the whole picture. For most people with a symptomatic bridge, a beta-blocker is where we begin, and for many it’s all they need. There’s some interest in one beta-blocker called nebivolol that may have an added benefit on the lining of the blood vessels, though any of the well-chosen options in this class can help. If you want to understand this family of medicines more deeply, I’ve written a separate guide to choosing a beta-blocker.

Calcium channel blockers are the main alternative or add-on. They relax the heart and the blood vessels and are a good choice for people who can’t tolerate a beta-blocker. They’re especially useful when there’s also a tendency for the artery to go into spasm, which can travel alongside bridging in some patients.

Ivabradine is a second-line option for people who need their heart rate slowed but can’t take beta-blockers or calcium channel blockers. It lowers heart rate through a different pathway. This is an off-label use for bridging, meaning it’s a reasonable, evidence-informed choice rather than an officially approved indication.

There’s one medicine we deliberately avoid, and it’s worth knowing why, because it runs against intuition. Nitroglycerin and other nitrates, the go-to relief for typical angina, tend to make bridge symptoms worse, not better. Nitrates widen the artery above and below the bridge and can actually accentuate the squeeze in the tunneled segment, sharpening the milking effect. So if you have a known symptomatic bridge and someone hands you nitroglycerin for chest pain, that can backfire. This is one of the clearest examples of why the bridge diagnosis matters: the treatment is genuinely different from the treatment for an ordinary blockage.

For the small group of people who stay symptomatic despite full medical therapy, there are procedural options, and these are reserved for refractory cases.

Surgical unroofing, also called myotomy, is the preferred procedure when one is needed. The surgeon divides the band of muscle lying over the artery, freeing the tunneled segment so it returns to the surface where it belongs. It fixes the underlying problem directly. It works best for bridges that are shorter and more superficial, and it improves symptoms and quality of life for the right candidates. It’s real heart surgery, with the risks that come with operating near the artery and muscle, including the chance of incomplete relief. One honest number to keep in mind: up to 60 percent of adults may have some return of chest pain by three years after the operation, which is thought to reflect lingering issues with the vessel lining rather than the bridge coming back. So even surgery isn’t a guaranteed permanent cure, which is one more reason we exhaust medical therapy first.

Bypass surgery is considered for very long bridges, over 25 millimeters, or very deep ones, 5 millimeters or more, where unroofing would be difficult. There’s a catch specific to bridges: because the native artery is still open and carries flow during relaxation, a bypass graft has to compete with it, and that competition causes grafts to fail at high rates. In one study, only about 10 percent of arterial grafts stayed open at 18 months, though vein grafts did considerably better at around 80 percent. This is why bypass is a carefully chosen option, not a default.

Stenting the bridge, the way we’d treat a blockage, is generally not advised. Putting a stent inside a segment that gets squeezed with every heartbeat leads to high rates of stent fracture, re-narrowing, and even artery rupture. Some centers will consider it for short, superficial bridges in select situations, but it’s not a routine answer. If you’d like to understand how stenting works in the settings where it does belong, I’ve covered that in my guide to heart catheterization and stenting.

What the Long-Term Outlook Looks Like

People understandably want to know what a bridge means for their future, and the honest answer is that it depends on the company the bridge keeps.

A large analysis published in 2026, pooling 22 studies and nearly 38,000 people, found that having a myocardial bridge was associated with a higher risk of major adverse cardiac events overall, with a hazard ratio of about 1.96, meaning roughly double the relative risk in the studied populations. At the same time, that same analysis found that bridging was not associated with a higher risk of death, either from heart causes or from any cause. So the data point toward a higher chance of events like chest-pain episodes or related problems, without a clear effect on survival. That’s a reassuring overall signal once you set the fear of the word aside.

The risk wasn’t spread evenly, though. It clustered in specific higher-risk groups. People with hypertrophic cardiomyopathy, a condition where the heart muscle is abnormally thickened, had a clearly higher risk when a bridge was also present, with a hazard ratio around 2.17. And people who already had high-risk coronary artery disease carried the highest risk of all, with a hazard ratio around 3.44. The theme is that a bridge tends to matter more when the heart already has another problem layered on. In an otherwise healthy heart, an isolated bridge is a much gentler finding. If you have thickened heart muscle, my guide to hypertrophic cardiomyopathy covers that condition in detail.

It’s worth balancing the 2026 analysis against another good study. The CORE320 study followed people with non-obstructive coronary disease for five years and found no difference in heart attack or death whether or not a bridge was present. Two careful looks at the question land in slightly different places, which is itself informative: the truth is that for most people a bridge is not a major driver of hard outcomes, and the people who need closer attention are those with additional heart conditions.

Two Groups Worth a Closer Look

A couple of populations deserve specific mention, because the bridge story shifts a little for them.

Competitive athletes. Bridges have rarely been linked to exercise-induced lack of blood flow and, even more rarely, to sudden cardiac events during intense exertion in young athletes. The bridges that raise the most concern in this setting are the long, deep ones, generally deeper than 3 millimeters. The word “rarely” is doing real work in that sentence. The overwhelming majority of athletes with a bridge are fine. But because the stakes in a young competitive athlete are high, a bridge found during a workup for exertional symptoms in that group gets evaluated thoroughly rather than waved off, often with the functional testing described earlier and a thoughtful conversation about training.

People with hypertrophic cardiomyopathy. As the prognosis data showed, bridges are both more common and more consequential in people with thickened heart muscle. The thick muscle squeezes harder, and the supply-demand balance is already strained, so a bridge in this setting is taken more seriously and folded into the overall management of the cardiomyopathy.

How I Think About It in Clinic

When a bridge lands on someone’s imaging report, my first job is to figure out which story we’re in. If you feel well, exercise without trouble, and the bridge turned up incidentally, the conversation is mostly reassurance, attention to your general heart-disease risk factors, and a plan to circle back if symptoms ever develop. That describes most people, and it deserves to be said plainly rather than buried under hedging.

If you do have symptoms, the next job is to make sure the bridge is actually the cause rather than a bystander, because chest pressure and breathlessness have many origins, and finding a bridge doesn’t automatically mean it’s to blame. That’s where stress testing and, in selected cases, the specialized pressure-wire and ultrasound studies come in. When the bridge is confirmed as the culprit, we start with a beta-blocker, steer clear of nitrates, and step through the options patiently. Surgery sits at the far end of that path, for the few who need it.

The thing I most want you to take from this is that a myocardial bridge is, for the large majority of people, a normal variation in how their heart was built. It’s worth understanding. It’s rarely worth fearing.

If you have a bridge on a scan and you’d like a clear read on what it means for you, our office is glad to help. To get in touch, visit our practice website. For advanced imaging, pressure-wire assessment, or a surgical opinion when one is warranted, we work with the team at San Diego Cardiovascular Associates. And if your real question is whether your chest symptoms are coming from your heart at all, start with my guide to cardiac chest pain.

Common Questions Patients Ask Me

Is a myocardial bridge dangerous?

For most people, no. It’s the most common congenital coronary variation, and it shows up in a large share of perfectly healthy hearts. The large majority of bridges cause no symptoms and no harm across an entire lifetime. A minority of people, usually those with deeper or longer bridges, or with another heart condition layered on top, can have symptoms and benefit from treatment. The pooled data suggest bridges raise the chance of cardiac events somewhat but don’t clearly affect survival.

Will I need surgery for my bridge?

Very likely not. Surgery is reserved for the small number of people who keep having symptoms despite full medical therapy. The first step is always medicine, usually a beta-blocker, and most people who have symptoms improve with that alone. If you have no symptoms, there’s nothing to operate on, and the bridge is simply an anatomical finding to be aware of.

Why was I told to avoid nitroglycerin?

Because nitrates can make a bridge worse rather than better. They widen the artery on either side of the buried segment and can sharpen the squeeze on the tunneled part, increasing the pinch with each heartbeat. Nitroglycerin is excellent for ordinary angina from a blockage, but a bridge behaves differently, which is a good example of why getting the diagnosis right changes the treatment.

Can I still exercise with a myocardial bridge?

In most cases, yes. The majority of people with a bridge exercise normally without any problem. If you’re having exertional chest pressure or breathlessness, that deserves evaluation before you push hard, and a competitive athlete with a deep or long bridge gets a more thorough workup because the stakes are higher. But a bridge by itself, without symptoms, is generally not a reason to stop being active. We tailor the advice to your specific situation.

How did they find my bridge if I feel fine?

Usually on a detailed scan done for another reason. Cardiac CT angiography is very good at showing bridges, and as more people get high-resolution heart imaging, more bridges turn up incidentally. A bridge found this way, in someone without symptoms, is the most common and most benign scenario. It means your anatomy has a common variation, not that you’ve developed a heart problem.

Is a bridge the same thing as a blocked artery?

No, and the difference matters. A blockage is a fixed narrowing built from cholesterol plaque inside the artery wall, and it’s there all the time. A bridge is an open, healthy artery that gets squeezed by overlying muscle during part of each heartbeat. The bridge segment is actually often the cleanest part of the vessel, protected from plaque, though the stretch of artery just above a bridge can be more prone to buildup. Because the mechanisms differ, the testing and treatment differ too.

References

  1. Sternheim, Daniel, David A. Power, Rajesh Samtani, et al. “Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review.” Journal of the American College of Cardiology 78, no. 22 (2021): 2196-2212.

  2. Tarantini, Giuseppe, Federico Migliore, Filippo Cademartiri, Chiara Fraccaro, and Sabino Iliceto. “Left Anterior Descending Artery Myocardial Bridging: A Clinical Approach.” Journal of the American College of Cardiology 68, no. 25 (2016): 2887-2899.

  3. Lawton, Jennifer S., Jacqueline E. Tamis-Holland, Sripal Bangalore, et al. “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.” Journal of the American College of Cardiology 79, no. 2 (2022): e21-e129.

  4. Ajmal, Muhammad, Bilal Javed, Saud Kubba, et al. “Contemporary Review of Myocardial Bridging for Internists.” The American Journal of Medicine 138, no. 6 (2025): 1014-1022.

  5. Bangalore, Sripal, William F. Fearon, Setri Fugar, et al. “Evidence-Based Practices in the Cardiac Catheterization Laboratory: Invasive Epicardial Coronary Physiologic Assessment: A Scientific Statement From the American Heart Association.” Circulation 151, no. 9 (2025): e645-e667.

  6. Roberts, William, Steven M. Charles, Christopher Ang, et al. “Myocardial Bridges: A Meta-Analysis.” Clinical Anatomy 34, no. 5 (2021): 685-709.

  7. Rodriguez, Bryan C., Renzo Laborante, Affan Rizwan, et al. “Myocardial Bridging: A Practical Guide for Clinicians.” European Heart Journal 47, no. 4 (2026): 351-364.

  8. Smilowitz, Nathaniel R., Megha Prasad, Robert J. Widmer, et al. “Comprehensive Management of ANOCA, Part 2: Program Development, Treatment, and Research Initiatives: JACC State-of-the-Art Review.” Journal of the American College of Cardiology 82, no. 12 (2023): 1264-1279.

  9. Alam, Yusra S., Hussein Nafakhi, Lina Mahdi, et al. “Prognostic Impact of Myocardial Bridge on Long-Term Mortality and Morbidity: A Meta-Analysis and Systematic Review.” The International Journal of Cardiovascular Imaging 42, no. 1 (2026): 1-13.

  10. Gannon, Michael P., Rodrigo J. Cerci, Carlos Valdiviezo, et al. “Combined Computed Tomography Angiography-Computed Tomography Perfusion in the Identification and Prognostic Assessment of Myocardial Bridging From the CORE320 Study: 5-Year Follow-Up.” The American Journal of Cardiology 207 (2023): 87-94.

  11. Thompson, Paul D., Robert J. Myerburg, Benjamin D. Levine, James E. Udelson, and Richard J. Kovacs. “Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease: A Scientific Statement From the American Heart Association and American College of Cardiology.” Journal of the American College of Cardiology 66, no. 21 (2015): 2406-2411.

Published on damianrasch.com. The above information was composed by Dr. Damian Rasch, drawing on individual insight and bolstered by digital research and writing assistance. The information is for educational purposes only and does not constitute medical advice.